NCT06860659View on ClinicalTrials.gov

Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye

PHASE4Enrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

May 26, 2025

Study Completion Date

June 26, 2025

Conditions

Dry Eye Disease (DED)Tear Break-Up TimeTear DisorderTear Film InsufficiencyTear Film HyperosmolarityDry EyeHyaluronateHyaluronic AcidCorneal StainingQuality of Life

Interventions

DRUG

0.28% Sodium Hyaluronate , preservative free eye drops

DRUG

0.18% Sodium Hyaluronate , preservative free eye drops

Trial Locations (1)

10400

Rajavithi Hospital, 2, Phayathai Road, Ratchathewi District, Bangkok

All Listed Sponsors

lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV

NCT06860659 - Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye | Biotech Hunter | Biotech Hunter